Literature DB >> 16896827

Changing trends in etiology of bacteremia in patients with cancer.

A Safdar1, G H Rodriguez, M Balakrishnan, J J Tarrand, K V I Rolston.   

Abstract

The present study was conducted to determine trends in the quantitative bacterial load patterns of bacterial bloodstream infections (BSI) caused by various bacteria in patients receiving care at a comprehensive cancer center. Bacterial loads of all consecutive quantitative blood cultures performed during 1998 and 2004 were graded quantitatively. Gram-positive bacteria (GPB) were responsible for the majority of BSI episodes in both years studied: 740 of 1,055 (73%) in 1998 and 820 of 1,025 (82%) in 2004. Compared with GPB infections, a significant proportion of infections caused by Gram-negative bacteria was associated with a high bacterial load (HBL) (11 vs 28% in 1998 and 10 vs 30% in 2004; p<0.001). In 2004, BSI episodes due to non-Pseudomonas non-fermentative GNB (Stenotrophomonas maltophilia and Acinetobacter spp) were significantly associated with a HBL compared to BSI due to Pseudomonas aeruginosa (47 vs 23%; p<0.05); this was not the case in 1998. Conversely, the HBLs commonly associated with BSI due to Staphylococcus aureus (50%) and Streptococcus spp (35%) versus coagulase-negative staphylococci (13%; p<0.0001) during 1998 were not noted during 2004 (22% Staphylococcus aureus, 20% Streptococcus spp, 21% coagulase-negative staphylococci; p>0.5). The spectrum of BSI continues to change and its prognostic implications in cancer patients needs further study.

Entities:  

Mesh:

Year:  2006        PMID: 16896827     DOI: 10.1007/s10096-006-0173-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Pseudomonas aeruginosa--still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center.

Authors:  K V Rolston; J J Tarrand
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.

Authors:  Chung-Hsu Lai; Chih-Yu Chi; Hsin-Pai Chen; Te-Li Chen; Chorng-Jang Lai; Chang-Phone Fung; Kwok-Woon Yu; Wing-Wai Wong; Cheng-Yi Liu
Journal:  J Microbiol Immunol Infect       Date:  2004-12       Impact factor: 4.399

Review 3.  Staphylococcus epidermidis: emerging resistance and need for alternative agents.

Authors:  I Raad; A Alrahwan; K Rolston
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

4.  In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.

Authors:  M J Enzler; M S Rouse; N K Henry; J E Geraci; W R Wilson
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

5.  Clinical significance of colony counts in immunocompromised patients with Staphylococcus aureus bacteremia.

Authors:  E Whimbey; T E Kiehn; P Brannon; D Benezra; D Armstrong
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

Review 6.  Infectious morbidity in critically ill patients with cancer.

Authors:  A Safdar; D Armstrong
Journal:  Crit Care Clin       Date:  2001-07       Impact factor: 3.598

7.  Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems.

Authors:  J J Tarrand; C Guillot; M Wenglar; J Jackson; J D Lajeunesse; K V Rolston
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study.

Authors:  Anucha Apisarnthanarak; Jennie L Mayfield; Teresa Garison; Patricia M McLendon; John F DiPersio; Victoria J Fraser; Louis B Polish
Journal:  Infect Control Hosp Epidemiol       Date:  2003-04       Impact factor: 3.254

9.  Quorum-sensing control of biofilm factors in Staphylococcus epidermidis.

Authors:  Cuong Vuong; Christiane Gerke; Greg A Somerville; Elizabeth R Fischer; Michael Otto
Journal:  J Infect Dis       Date:  2003-08-11       Impact factor: 5.226

10.  Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis.

Authors:  R J Backes; M S Rouse; N K Henry; J E Geraci; W R Wilson
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

View more
  12 in total

1.  Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009.

Authors:  H Araoka; M Baba; A Yoneyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-23       Impact factor: 3.267

2.  Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients.

Authors:  Hayati Demiraslan; Mustafa Sevim; Çiğdem Pala; Süleyman Durmaz; Veli Berk; Leylagül Kaynar; Gökhan Metan
Journal:  Int J Hematol       Date:  2013-02-22       Impact factor: 2.490

3.  An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality.

Authors:  Ritvan Kara Ali; Serkan Surme; Ilker Inanc Balkan; Ayse Salihoglu; Meryem Sahin Ozdemir; Yusuf Ozdemir; Bilgul Mete; Gunay Can; Muhlis Cem Ar; Fehmi Tabak; Nese Saltoglu
Journal:  Ann Hematol       Date:  2020-06-20       Impact factor: 3.673

4.  Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia.

Authors:  Cheol-In Kang; Jae-Hoon Song; Doo Ryeon Chung; Kyong Ran Peck; Joon-Sup Yeom; Jun Seong Son; Yu Mi Wi
Journal:  Support Care Cancer       Date:  2011-12-23       Impact factor: 3.603

5.  Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides.

Authors:  Hemamali J Warshakoon; Mark R Burns; Sunil A David
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

Review 6.  The era of molecular and other non-culture-based methods in diagnosis of sepsis.

Authors:  Nicasio Mancini; Silvia Carletti; Nadia Ghidoli; Paola Cichero; Roberto Burioni; Massimo Clementi
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells.

Authors:  Matthew R Kimbrell; Hemamali Warshakoon; Jens R Cromer; Subbalakshmi Malladi; Jennifer D Hood; Rajalakshmi Balakrishna; Tandace A Scholdberg; Sunil A David
Journal:  Immunol Lett       Date:  2008-04-18       Impact factor: 3.685

Review 8.  Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  S Neumann; S W Krause; G Maschmeyer; X Schiel; M von Lilienfeld-Toal
Journal:  Ann Hematol       Date:  2013-02-15       Impact factor: 3.673

9.  Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Morena Caira; Anna Candoni; Domenico Pastore; Chiara Cattaneo; Rosa Fanci; Annamaria Nosari; Antonio Spadea; Alessandro Busca; Nicola Vianelli; Teresa Spanu; Livio Pagano
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria.

Authors:  Martin Hoenigl; Jasmin Wagner; Reinhard B Raggam; Florian Prueller; Juergen Prattes; Susanne Eigl; Eva Leitner; Katharina Hönigl; Thomas Valentin; Ines Zollner-Schwetz; Andrea J Grisold; Robert Krause
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.